Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Wells

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Scleroderma and Related Disorders|June 8, 2026
Influence of comorbidities and patient demographics on Raynaud's symptom characteristics: implications for diagnosis and managementReshma Seomore, Matthew Wells, Ula Tymoszuk, et al.
Rheumatology (Oxford, England)|May 22, 2026
The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosisMatthew Wells, Theresa Smith, Robyn T Domsic, et al.
Prehospital Emergency Care|February 1, 2022
Performance of Prehospital Use of Chest Pain Risk Stratification Tools: The RESCUE StudyJason P Stopyra, Anna C Snavely, Nicklaus P Ashburn, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
A Retrospective Analysis of 2-Year Follow-Up of Patients with Incidental Findings of SarcoidosisOluwabukola Thomas-Orogan, Shaney L Barratt, Muhammad Zafran, et al.
Haematologica|May 14, 2026
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencingWendy Osborne, Euan Haynes, William Wilson, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Scleroderma and Related Disorders|June 8, 2026
Influence of comorbidities and patient demographics on Raynaud's symptom characteristics: implications for diagnosis and managementReshma Seomore, Matthew Wells, Ula Tymoszuk, et al.
Rheumatology (Oxford, England)|May 22, 2026
The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosisMatthew Wells, Theresa Smith, Robyn T Domsic, et al.
Prehospital Emergency Care|February 1, 2022
Performance of Prehospital Use of Chest Pain Risk Stratification Tools: The RESCUE StudyJason P Stopyra, Anna C Snavely, Nicklaus P Ashburn, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
A Retrospective Analysis of 2-Year Follow-Up of Patients with Incidental Findings of SarcoidosisOluwabukola Thomas-Orogan, Shaney L Barratt, Muhammad Zafran, et al.
Haematologica|May 14, 2026
Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencingWendy Osborne, Euan Haynes, William Wilson, et al.
Pageof 5